BarxCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。Barx遺伝子サイレンサーは、Barx CRISPR/Cas9ノックアウトプラスミドとBarxDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のBarxCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
Barx CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
Barx1 CRISPR/Cas9 KOプラスミド (h) | sc-406951 | h | Gene Knockout | GFP | 0 | ||
Barx1 HDRプラスミド (h) | sc-406951-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Barx1 Double Nickaseプラスミド (h) | sc-406951-NIC | h | Gene Knockout | Puromycin | 0 | ||
Barx1 Double Nickaseプラスミド (h2) | sc-406951-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Barx1 CRISPR/Cas9 KOプラスミド (m) | sc-419290 | m | Gene Knockout | GFP | 0 | ||
Barx1 HDRプラスミド (m) | sc-419290-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Barx1 Double Nickaseプラスミド (m) | sc-419290-NIC | m | Gene Knockout | Puromycin | 0 | ||
Barx1 Double Nickaseプラスミド (m2) | sc-419290-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Barx2 CRISPR/Cas9 KOプラスミド (h) | sc-403458 | h | Gene Knockout | GFP | 0 | ||
Barx2 HDRプラスミド (h) | sc-403458-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Barx2 Double Nickaseプラスミド (h) | sc-403458-NIC | h | Gene Knockout | Puromycin | 0 | ||
Barx2 Double Nickaseプラスミド (h2) | sc-403458-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Barx2 CRISPR/Cas9 KOプラスミド (m) | sc-419291 | m | Gene Knockout | GFP | 0 | ||
Barx2 HDRプラスミド (m) | sc-419291-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Barx2 Double Nickaseプラスミド (m) | sc-419291-NIC | m | Gene Knockout | Puromycin | 0 | ||
Barx2 Double Nickaseプラスミド (m2) | sc-419291-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Barx CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
Barx1 CRISPR Activationプラスミド (h) | sc-406951-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 CRISPR Activationプラスミド (h2) | sc-406951-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 Lentiviral Activation Particles (h) | sc-406951-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 Lentiviral Activation Particles (h2) | sc-406951-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 CRISPR Activationプラスミド (m) | sc-419290-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 CRISPR Activationプラスミド (m2) | sc-419290-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 Lentiviral Activation Particles (m) | sc-419290-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx1 Lentiviral Activation Particles (m2) | sc-419290-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 CRISPR Activationプラスミド (h) | sc-403458-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 CRISPR Activationプラスミド (h2) | sc-403458-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 Lentiviral Activation Particles (h) | sc-403458-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 Lentiviral Activation Particles (h2) | sc-403458-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 CRISPR Activationプラスミド (m) | sc-419291-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 CRISPR Activationプラスミド (m2) | sc-419291-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 Lentiviral Activation Particles (m) | sc-419291-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Barx2 Lentiviral Activation Particles (m2) | sc-419291-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |